Stevens Capital Management LP Bio Techne Corp Transaction History

Stevens Capital Management LP

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$71.62 - $86.62 $379,156 - $458,566	5,294 New	5,294 $393,000
Q4 2021 Jan 28, 2022	SELL	$456.15 - $525.06 $265,935 - $306,109	-583 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$444.87 - $538.88 $259,359 - $314,167	583 New	583 $283,000
Q3 2019 Nov 08, 2019	SELL	$183.56 - $216.72 $745,070 - $879,666	-4,059 Closed	0 $0
Q2 2019 Jul 31, 2019	BUY	$188.72 - $215.43 $766,014 - $874,430	4,059 New	4,059 $846,000
Q1 2019 May 03, 2019	SELL	$136.09 - $200.44 $384,862 - $566,844	-2,828 Closed	0 $0
Q4 2018 Feb 06, 2019	SELL	$132.75 - $203.8 $1.5 Million - $2.3 Million	-11,296 Reduced 79.98%	2,828 $409,000
Q3 2018 Nov 13, 2018	BUY	$147.44 - $204.11 $2.08 Million - $2.88 Million	14,124 New	14,124 $2.88 Million
Q2 2018 Aug 09, 2018	SELL	$144.9 - $165.58 $1.22 Million - $1.39 Million	-8,395 Closed	0 $0
Q1 2018 May 08, 2018	BUY	$131.46 - $151.04 $696,212 - $799,907	5,296 Added 170.89%	8,395 $1.27 Million
Q4 2017 Feb 13, 2018	BUY	$121.17 - $134.75 $375,505 - $417,590	3,099	3,099 $401,000

601

151M

195K

53.2K

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.8B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

Get notified when there are updates to the investment portfolio of Stevens Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Stevens Capital Management LP with notifications on news.